Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment

by Dr. Rich on December 19, 2012

Conclusion: Mood and substance use comorbidity is prevalent among patients seeking primary care office-based buprenorphine/naloxone treatment. The findings support the need for clinicians to assess and address these conditions. (Source: Drug and Alcohol Dependence)

MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Previous post:

Next post: